Respondents to Ipsos' Public Affair's latest iRep reputation poll (conducted biannually)described pharma as "making a profit at the expense of the consumer." 32% rated it unfavorably, 35% favorably and the rest, neither way. Medical devices fared much better, with a 48% favorable rating. To read the report's executive summary, complete with pie charts, click here.
